Compare Bank Maspion Indonesia Tbk. (BMAS) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank Maspion Indonesia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Bank Maspion Indonesia Tbk. trades at Rp474 (market cap 8.53T, 2.4K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp147 (market cap 576.7B, 3.19M 24h volume). The key difference: Bank Maspion Indonesia Tbk. is far larger — about 14.8× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.19M versus 2.4K). Which is the better fit depends on your goals.
| BMAS | LABS | |
|---|---|---|
Market Cap | 8.53T | 576.7B |
Volume | 2.4K | 3.19M |
Lot | 24 | 31.91K |
Turnover | 1.14M | 479.89M |
Average Price | 473.92 | 150.38 |
Value | 1.14M | 479.89M |
Indicative Equilibrium Price | — | 147 |
Indicative Equilibrium Volume | — | 311 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank Maspion Indonesia Tbk.
PT Bank Maspion Indonesia Tbk (the Bank) was established on November 6, 1989 based on Notarial Deed No. 68 of Soetjipto, S.H., which was amended by Notarial Deed No. 49 dated December 5, 1989 of the same notary. The Bank started its commercial operations in 1990. As of December 31, 2012, the Bank has 10 domestic branches, 27 sub-branches, 10 cash offices and 45 Automatic Teller Machines (ATMs) located at Surabaya, Jakarta, Semarang, Denpasar, Medan, Bandung, Makassar, Malang, Solo and Purwokerto.
Read more on BMAS →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
